Regenerx Biopharmaceuticals Inc (RGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGRX | MRNA | BMY | AMGN | BNTX |
| Company | Regenerx Biopharmaceuticals Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Biontech Se ADR |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0014 | 102.53 | 47.93 | 265.64 | 85.67 |
| High | 0.0014 | 103.51 | 48.20 | 265.92 | 86.77 |
| Low | 0.0014 | 99.90 | 47.62 | 263.25 | 85.61 |
| Last | 0.0014 | 102.42 | 48.01 | 263.87 | 85.99 |
| Change | -0.0508 | -1.02 | +0.17 | -0.20 | -0.41 |
| % Change | -97.32% | -0.99% | +0.36% | -0.08% | -0.47% |
| Volume | 200 | 786,875 | 3,613,523 | 496,342 | 227,910 |
| 20-Day Average Volume | 840 | 3,190,842 | 11,039,845 | 2,121,093 | 560,768 |
| Previous Close | 0.0522 | 103.44 | 47.84 | 264.07 | 86.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0037 | 105.48 | 50.98 | 273.04 | 89.89 |
| 20-Day Raw Stochastic | 1.93% | 29.12% | 6.87% | 3.67% | 8.05% |
| 20-Day Relative Strength | 37.79% | 49.37% | 36.28% | 37.78% | 38.81% |
| Weighted Alpha | -31.09 | -19.22 | -30.56 | +5.05 | -28.31 |
| Today's Opinion | 100% Sell | 72% Buy | 72% Sell | 56% Sell | 100% Sell |
| Previous Opinion | 88% Sell | 72% Buy | 56% Sell | 56% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 56% Buy | 24% Sell | 8% Sell | 80% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +16.67% since 03/11/24 | -4.21% since 04/11/24 | -2.08% since 04/11/24 | -2.16% since 04/11/24 | -1.07% since 04/11/24 |
| Low | 0.0012 on 03/20/24 | 99.90 on 04/18/24 | 47.63 on 04/18/24 | 263.25 on 04/18/24 | 85.40 on 04/17/24 |
| High | 0.0522 on 04/10/24 | 107.88 on 04/12/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 88.96 on 04/15/24 |
| 1-Month | |||||
| %Chg | +16.67% since 03/11/24 | -1.69% since 03/18/24 | -6.76% since 03/18/24 | -2.48% since 03/18/24 | -7.43% since 03/18/24 |
| Low | 0.0012 on 03/20/24 | 97.00 on 04/03/24 | 47.63 on 04/18/24 | 263.25 on 04/18/24 | 85.21 on 03/20/24 |
| High | 0.0522 on 04/10/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 94.44 on 03/19/24 |
| 3-Month | |||||
| %Chg | +16.67% since 01/17/24 | +3.46% since 01/18/24 | -3.97% since 01/18/24 | -13.24% since 01/18/24 | -11.74% since 01/18/24 |
| Low | 0.0012 on 03/20/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 263.25 on 04/18/24 | 85.21 on 03/20/24 |
| High | 0.0522 on 04/10/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 101.13 on 01/24/24 |
| 6-Month | |||||
| %Chg | -99.86% since 10/17/23 | +19.17% since 10/18/23 | -15.39% since 10/18/23 | -6.84% since 10/18/23 | -8.79% since 10/18/23 |
| Low | 0.0002 on 11/03/23 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 85.21 on 03/20/24 |
| High | 0.0522 on 04/10/24 | 115.97 on 01/08/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 114.69 on 01/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2 | 39,605,108 | 96,960,152 | 141,520,144 | 20,539,524 |
| Shares Outstanding, K | 1,509 | 382,880 | 2,026,759 | 535,919 | 237,726 |
| Annual Sales | 80,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 4,133,300,000 |
| Annual Net Income | -1,730,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 1,006,860,000 |
| Last Quarter Sales | 20,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 1,605,270,000 |
| Last Quarter Net Income | -390,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 500,620,000 |
| 60-Month Beta | 2.57 | 1.62 | 0.39 | 0.58 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 2.05 on 03/20/24 |
| Latest Earnings Date | 01/02/23 | 05/02/24 | 04/25/24 | 05/02/24 | 05/06/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 3.084 on 06/02/22 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 06/02/22 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.43 | 14.24 | 20.96 |